Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

SELL
$57.89 - $64.73 $2.35 Million - $2.63 Million
-40,607 Reduced 76.18%
12,698 $736,000
Q2 2023

Jul 13, 2023

SELL
$63.71 - $70.74 $5.26 Million - $5.84 Million
-82,515 Reduced 60.75%
53,305 $3.41 Million
Q1 2023

Apr 14, 2023

BUY
$65.71 - $74.53 $274,273 - $311,088
4,174 Added 3.17%
135,820 $9.41 Million
Q4 2022

Jan 12, 2023

SELL
$68.48 - $81.09 $156,887 - $185,777
-2,291 Reduced 1.71%
131,646 $0
Q3 2022

Oct 21, 2022

BUY
$0.13 - $76.84 $323 - $191,331
2,490 Added 1.89%
133,937 $9.52 Million
Q2 2022

Jul 15, 2022

SELL
$72.62 - $79.98 $350,173 - $385,663
-4,822 Reduced 3.54%
131,447 $10.2 Million
Q1 2022

Apr 25, 2022

SELL
$61.48 - $73.72 $81,891 - $98,195
-1,332 Reduced 0.97%
136,269 $9.95 Million
Q4 2021

Jan 26, 2022

SELL
$53.63 - $62.52 $312,448 - $364,241
-5,826 Reduced 4.06%
137,601 $8.58 Million
Q3 2021

Oct 15, 2021

BUY
$59.17 - $69.31 $1.76 Million - $2.06 Million
29,775 Added 26.2%
143,427 $8.49 Million
Q2 2021

Jul 20, 2021

BUY
$61.91 - $67.42 $3.38 Million - $3.68 Million
54,523 Added 92.21%
113,652 $7.59 Million
Q1 2021

Apr 22, 2021

BUY
$59.34 - $66.74 $415,795 - $467,647
7,007 Added 13.44%
59,129 $3.73 Million
Q4 2020

Jan 20, 2021

SELL
$57.74 - $65.43 $2.62 Million - $2.97 Million
-45,330 Reduced 46.52%
52,122 $3.23 Million
Q3 2020

Oct 21, 2020

SELL
$57.43 - $63.64 $127,666 - $141,471
-2,223 Reduced 2.23%
97,452 $5.88 Million
Q2 2020

Jul 22, 2020

BUY
$54.82 - $64.09 $510,977 - $597,382
9,321 Added 10.32%
99,675 $5.86 Million
Q1 2020

Apr 30, 2020

BUY
$46.4 - $67.43 $3.51 Million - $5.11 Million
75,735 Added 518.06%
90,354 $5.04 Million
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $18,798 - $24,520
382 Added 2.68%
14,619 $938,000
Q3 2019

Oct 24, 2019

SELL
$42.77 - $50.71 $485,738 - $575,913
-11,357 Reduced 44.37%
14,237 $722,000
Q2 2019

Jul 30, 2019

BUY
$44.62 - $49.34 $1.14 Million - $1.26 Million
25,594 New
25,594 $1.16 Million
Q2 2018

Aug 03, 2018

SELL
$50.53 - $62.98 $206,516 - $257,399
-4,087 Closed
0 $0
Q3 2017

Oct 19, 2017

BUY
$55.23 - $63.74 $225,725 - $260,505
4,087
4,087 $261,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Transform Wealth, LLC Portfolio

Follow Transform Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transform Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transform Wealth, LLC with notifications on news.